107 related articles for article (PubMed ID: 27234550)
1. Effect of Acarbose, Sitagliptin and combination therapy on blood glucose, insulin, and incretin hormone concentrations in experimentally induced postprandial hyperglycemia of healthy cats.
Mori A; Ueda K; Lee P; Oda H; Ishioka K; Arai T; Sako T
Res Vet Sci; 2016 Jun; 106():131-4. PubMed ID: 27234550
[TBL] [Abstract][Full Text] [Related]
2. Effects of miglitol, sitagliptin or their combination on plasma glucose, insulin and incretin levels in non-diabetic men.
Aoki K; Masuda K; Miyazaki T; Togashi Y; Terauchi Y
Endocr J; 2010; 57(8):667-72. PubMed ID: 20519806
[TBL] [Abstract][Full Text] [Related]
3. Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
Tsuchimochi W; Ueno H; Yamashita E; Tsubouchi C; Sakoda H; Nakamura S; Nakazato M
Endocr J; 2015; 62(1):13-20. PubMed ID: 25252844
[TBL] [Abstract][Full Text] [Related]
4. The incretin effect in cats: comparison between oral glucose, lipids, and amino acids.
Gilor C; Graves TK; Gilor S; Ridge TK; Weng HY; Dossin O
Domest Anim Endocrinol; 2011 May; 40(4):205-12. PubMed ID: 21397435
[TBL] [Abstract][Full Text] [Related]
5. Effects of sitagliptin on plasma incretin concentrations after glucose administration through an esophagostomy tube or feeding in healthy cats.
Nishii N; Takashima S; Iguchi A; Murahata Y; Matsuu A; Hikasa Y; Kitagawa H
Domest Anim Endocrinol; 2014 Oct; 49():14-9. PubMed ID: 25010023
[TBL] [Abstract][Full Text] [Related]
6. Effects of consumption of main and side dishes with white rice on postprandial glucose, insulin, glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 responses in healthy Japanese men.
Kameyama N; Maruyama C; Matsui S; Araki R; Yamada Y; Maruyama T
Br J Nutr; 2014 May; 111(9):1632-40. PubMed ID: 24507870
[TBL] [Abstract][Full Text] [Related]
7. Effect of single-dose DPP-4 inhibitor sitagliptin on β-cell function and incretin hormone secretion after meal ingestion in healthy volunteers and drug-naïve, well-controlled type 2 diabetes subjects.
Alsalim W; Göransson O; Carr RD; Bizzotto R; Tura A; Pacini G; Mari A; Ahrén B
Diabetes Obes Metab; 2018 Apr; 20(4):1080-1085. PubMed ID: 29227575
[TBL] [Abstract][Full Text] [Related]
8. Effects of Miglitol, Acarbose, and Sitagliptin on Plasma Insulin and Gut Peptides in Type 2 Diabetes Mellitus: A Crossover Study.
Ueno H; Tsuchimochi W; Wang HW; Yamashita E; Tsubouchi C; Nagamine K; Sakoda H; Nakazato M
Diabetes Ther; 2015 Jun; 6(2):187-96. PubMed ID: 26055217
[TBL] [Abstract][Full Text] [Related]
9. Miglitol administered before breakfast increased plasma active glucagon-like peptide-1 (GLP-1) levels after lunch in patients with type 2 diabetes treated with sitagliptin.
Aoki K; Kamiyama H; Yoshimura K; Shibuya M; Masuda K; Terauchi Y
Acta Diabetol; 2012 Jun; 49(3):225-30. PubMed ID: 21898126
[TBL] [Abstract][Full Text] [Related]
10. Circulating concentrations of glucagon-like peptide 1, glucose-dependent insulinotropic peptide, peptide YY, and insulin in client-owned lean, overweight, and diabetic cats.
McMillan CJ; Zapata RC; Chelikani PK; Snead EC; Cosford K
Domest Anim Endocrinol; 2016 Jan; 54():85-94. PubMed ID: 26609567
[TBL] [Abstract][Full Text] [Related]
11. Effects of sitagliptin and metformin treatment on incretin hormone and insulin secretory responses to oral and "isoglycemic" intravenous glucose.
Vardarli I; Arndt E; Deacon CF; Holst JJ; Nauck MA
Diabetes; 2014 Feb; 63(2):663-74. PubMed ID: 24186866
[TBL] [Abstract][Full Text] [Related]
12. Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.
Rosak C; Hofmann U; Paulwitz O
Diabetes Nutr Metab; 2004 Jun; 17(3):137-42. PubMed ID: 15334790
[TBL] [Abstract][Full Text] [Related]
13. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
Rosak C; Haupt E; Walter T; Werner J
Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
[TBL] [Abstract][Full Text] [Related]
14. Influence of various carbohydrate sources on postprandial glucose, insulin and NEFA concentrations in obese cats.
Mori A; Ueda K; Lee P; Oda H; Ishioka K; Sako T
Pol J Vet Sci; 2016; 19(2):387-91. PubMed ID: 27487514
[TBL] [Abstract][Full Text] [Related]
15. The incretin effect in critically ill patients: a case-control study.
Nielsen ST; Janum S; Krogh-Madsen R; Solomon TP; Møller K
Crit Care; 2015 Nov; 19():402. PubMed ID: 26567860
[TBL] [Abstract][Full Text] [Related]
16. Insulin secretory effect of sitagliptin: assessment with a hyperglycemic clamp combined with a meal challenge.
Shankar SS; Shankar RR; Mixson LA; Miller DL; Steinberg HO; Beals CR; Kelley DE
Am J Physiol Endocrinol Metab; 2018 Apr; 314(4):E406-E412. PubMed ID: 29138226
[TBL] [Abstract][Full Text] [Related]
17. Soya milk exerts different effects on plasma amino acid responses and incretin hormone secretion compared with cows' milk in healthy, young men.
Sun L; Tan KW; Siow PC; Henry CJ
Br J Nutr; 2016 Oct; 116(7):1216-1221. PubMed ID: 27609509
[TBL] [Abstract][Full Text] [Related]
18. Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes.
Herman GA; Bergman A; Stevens C; Kotey P; Yi B; Zhao P; Dietrich B; Golor G; Schrodter A; Keymeulen B; Lasseter KC; Kipnes MS; Snyder K; Hilliard D; Tanen M; Cilissen C; De Smet M; de Lepeleire I; Van Dyck K; Wang AQ; Zeng W; Davies MJ; Tanaka W; Holst JJ; Deacon CF; Gottesdiener KM; Wagner JA
J Clin Endocrinol Metab; 2006 Nov; 91(11):4612-9. PubMed ID: 16912128
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic enzyme supplementation improves the incretin hormone response and attenuates postprandial glycemia in adolescents with cystic fibrosis: a randomized crossover trial.
Perano SJ; Couper JJ; Horowitz M; Martin AJ; Kritas S; Sullivan T; Rayner CK
J Clin Endocrinol Metab; 2014 Jul; 99(7):2486-93. PubMed ID: 24670086
[TBL] [Abstract][Full Text] [Related]
20. Use of Sitagliptin With Closed-Loop Technology to Decrease Postprandial Blood Glucose in Type 1 Diabetes.
Underland LJ; Ilkowitz JT; Katikaneni R; Dowd A; Heptulla RA
J Diabetes Sci Technol; 2017 May; 11(3):602-610. PubMed ID: 28349708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
